Biogen‘s Alzheimer treatment triggers debate regarding its real-world benefits

The post Biogen‘s Alzheimer treatment triggers debate regarding its real-world benefits appeared on BitcoinEthereumNews.com.

Biogen (NASDAQ: BIIB) launched in June a new Alzheimer’s disease drug but its uptake so far has been slow, leading one notable Wall Street analyst to recommend a cautious approach…

Leave a Reply

Your email address will not be published. Required fields are marked *